# Hybrid Therapy and Heart Team for Atrial Fibrillation

> **NCT03737929** · NA · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 228 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Hybrid ablation
- **PROCEDURE:** Percutaneous catheter ablation

## Key facts

- **NCT ID:** NCT03737929
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-07-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 228 (ESTIMATED)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03737929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03737929, "Hybrid Therapy and Heart Team for Atrial Fibrillation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03737929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*